NPPA Fixes Retail Price of 19 Formulations; Details
New Delhi: Through a recent notice, the National Pharmaceutical Pricing Authority (NCPA), Ministry of Chemicals and Fertilizers, Government of India has fixed price of 19 formulations.
These include formulations like Ibuprofen and Paracetamol Tablet; Vildagliptin and Metformin Hydrochloride (as sustained release) Tablet; Povidone IodineTopical Solution 1% and
This came in exercise of the powers conferred by paragraphs 5, 11 and 15 of the Drugs (Prices Control) Order, 2013, read with S.O. 1394(E) dated the 30th May, 2013 and S. O. 701(E) dated 10th March, 2016 issued by the Government of India in the Ministry of Chemicals and Fertilizers, the National Pharmaceutical Pricing Authority (hereinafter referred as NPPA), hereby fixes, the price as specified in column (6) of the table herein below as the retail price, exclusive of Goods and Services Tax, if any, in relation to the formulation specified in the corresponding entry in column (2) of the said Table with the strength, unit and name of manufacturer & marketing company, as specified in the corresponding entries in columns (3), (4) and (5) thereof;
Sl. No. | Name of the Formulation / Brand Name | Strength | Unit | Manufacturer & Marketing Company | Retail Price (Rs.) |
(1) | (2) | (3) | (4) | (5) | (6) |
1. | Mesalazine Suppositories BP 1g | Each Suppository contains: Mesalazine IP 1g | 1 Suppos itory | M/s Bliss GVS Pharma Ltd. / M/s Cipla Limited | 97.88 |
2. | Telmisartan + Chlorthalidone + Amlodipine Tablet | Each film coated tablet contains: Telmisartan IP 40mg, Chlorthalidone IP 6.25mg, Amlodipine Besilate IP eq. to Amlodipine 5mg | 1 Tablet | M/s Micro Labs Limited | 8.39 |
3. | Ceftiazone + Sulbactum for Injection (ZIFI SB) | The Combipack contains:
Sterile Water for Injections IP 10ml | Per Combi Pack | M/s Zen Pharma (P) Limited / M/s FDC Limited | 120.3 4 |
4. | Diclofenac + Thiocolchicoside + Linseed Oil + Methyl Salicylate + Menthol Gel | Composition: Diclofenac Diethylamine IP 1.16%w/w (eq. to Diclofenac Sodium 1.0%w/w), Thiocolchicoside IP 0.125% w/w, Linseed Oil BP 3% w/w, Methyl Salicylate IP 10%w/w Menthol IP 5%w/w | 1 GM | M/s Pure and Cure Healthcare Pvt. Ltd. / M/s Zydus Healthcare Limited | 5.23 |
Sl. No. | Name of the Formulation / Brand Name | Strength | Unit | Manufacturer & Marketing Company | Retail Price (Rs.) |
(1) | (2) | (3) | (4) | (5) | (6) |
5. | Ciprofloxacin + Dexamethasone Eye Drops | Composition: Ciprofloxacin Hydrochloride IP Eq. to Ciprofloxacin 0.3% w/v, Dexamethasone IP 0.1% w/v, | 1 ML | M/s Skymap Healthcare Pvt. Ltd. / M/s Glensmith Labs Pvt. Ltd. | 1.33 |
6. | Ciprofloxacin + Dexamethasone Eye Drops | Composition: Ciprofloxacin Hydrochloride IP Eq. to Ciprofloxacin 0.3% w/v, Dexamethasone IP 0.1% w/v, | 1 ML | M/s Skymap Healthcare Pvt. Ltd. | 1.33 |
7. | Phenylephrine HCl + Chlorpheniramin e Maleate + Sodium Citrate + Menthol Syrup | Each 5ml contains: Phenylephrine HCl IP 5mg, Chlorpheniramine Maleate IP 1mg Sodium Citrate IP 60mg, Menthol IP 1mg | 1 ML | M/s Enicar Pharmaceuticals Pvt. Ltd. / M/s Group Pharmaceuticals Ltd. | 0.90 |
8. | Omeprazole for Injection | Each vial contains: Omeprazole IP (Sterile) 40mg (As Sodium Suitably buffered) Water for Injection IP q. s. | Per Pack | M/s Skymap Healthcare Pvt. Ltd. / M/s German Remedies Pharmaceuticals Pvt. Ltd. | 34.86 |
9. | Metoprolol Injection | Each ml contains: Metoprolol Tartrate IP 1mg Water for injection IP q. s. | Per Pack | M/s Skymap Healthcare Pvt. Ltd. / M/s German Remedies Pharmaceuticals Pvt. Ltd. | 13.53 |
10. | Norethisterone Acetate Controlled Release Tablet | Each film coated controlled release tablet contains: Norethisterone Acetate BP 10mg | 1 Tablet | M/s Akums Drugs & Pharmaceuticals Ltd. / M/s Cadila Pharmaceuticals Limited | 15.09 |
11. | Ibuprofen + Paracetamol Tablet | Each uncoated tablet contains: Ibuprofen IP 400mg Paracetamol IP 325mg | 1 Tablet | M/s Vapi Care Pharma Pvt. Ltd. /M/s Alembic Pharmaceuticals Lmited | 1.11 |
12. | Moxifloxacin Hydrochloride + Dexamethasone Phosphate Eye Drops | Each ml contains: Moxifloxacin Hydrochloride IP eq. to Moxifloxacin 0.5% w/v Dexamethasone Sodium Phosphate IP eq. to Dexamethasone Phosphate 0.1% w/v | 1 ml | M/s Skymap Healthcare Pvt. Ltd. / M/s Glensmith Labs Pvt. Ltd. | 19.07 |
Sl. No. | Name of the Formulation / Brand Name | Strength | Unit | Manufacturer & Marketing Company | Retail Price (Rs.) |
(1) | (2) | (3) | (4) | (5) | (6) |
13. | Povidone-Iodine Gargle 0.5% w/v | Composition: Povidone-Iodine IP 0.5% w/v (available Iodine 0.06% w/v) | 1 ml | M/s Windlas Biotech Pvt. Ltd. / M/s Mankind Pharma Limited | 0.79 |
14. | Trihexyphenidyl Hydrochloride Tablet | Each uncoated tablet contains: Trihexyphenidyl Hydrochloride IP 1mg | 1 Tablet | M/s D. D. Pharmaceuticals Pvt. Ltd. | 0.73 |
15. | Azelnidipine + Telmisartan Tablet | Each film coated bi-layered tablet contains: Azelnidipine IP 8mg Telmisartan IP 40mg | 1 Tablet | M/s Synokem Pharmaceuticals Limited / M/s Torrent Pharmaceuticals Ltd. | 12.45 |
16. | Azelnidipine + Telmisartan Tablet | Each film coated bi-layered tablet contains: Azelnidipine IP 8mg Telmisartan IP 80mg | 1 Tablet | M/s Synokem Pharmaceuticals Limited / M/s Torrent Pharmaceuticals Ltd. | 14.20 |
17. | Vildagliptin + Metformin Hydrochloride (as sustained release) Tablet | Each uncoated bilayered tablet contains: Vildagliptin 50mg, Metformin Hydrochloride IP (As sustained release) 500mg | 1 Tablet | M/s Exemed Pharmaceuticals / M/s Eris Life Sciences Limited | 6.58 |
18. | Vildagliptin + Metformin Hydrochloride (as sustained release) Tablet | Each uncoated bilayered tablet contains: Vildagliptin 50mg, Metformin Hydrochloride IP (As sustained release) 1000mg | 1 Tablet | M/s Exemed Pharmaceuticals / M/s Eris Life Sciences Limited | 7.07 |
19. | Povidone IodineTopical Solution 1%w/v | Each 100ml contains: Povidone Iodine IP 1.0g (Available Iodine 0.1g) 2-Propanol IP 50g In an aqueous base | Per 200ml Pack | M/s G.S. Pharmbutor Pvt. Ltd./M/s Win- Medicare Pvt. Ltd. | 92.00 |
The NPPA notice further added;
Disclaimer: This website is primarily for healthcare professionals. The content here does not replace medical advice and should not be used as medical, diagnostic, endorsement, treatment, or prescription advice. Medical science evolves rapidly, and we strive to keep our information current. If you find any discrepancies, please contact us at corrections@medicaldialogues.in. Read our Correction Policy here. Nothing here should be used as a substitute for medical advice, diagnosis, or treatment. We do not endorse any healthcare advice that contradicts a physician's guidance. Use of this site is subject to our Terms of Use, Privacy Policy, and Advertisement Policy. For more details, read our Full Disclaimer here.
NOTE: Join us in combating medical misinformation. If you encounter a questionable health, medical, or medical education claim, email us at factcheck@medicaldialogues.in for evaluation.